1st Quarter - Report
NOVEL STRATEGIES (FKA) PRISM GROUP for THE ALLIANCE FOR LONGEVITY INITIATIVES
Income
$20,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Directing the Food and Drug Administration to create a pathway for longevity treatment. Reauthorization of the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs at the National Institutes of Health.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN GUY | — |
Budget/Appropriations BUD
Increased funding for longevity research at the National Institutes of Health
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN GUY New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.